Please wait
Healthcare · Medical Devices · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$67.9B
N/A
18.96
Current price
$48.55
+3.7% todayUpdated 3 min ago
Open
$46.62
Previous close
$46.84
Day range
$46.09 – $48.97
Volume
N/A
19.0x P/E
Awaiting filing
No current yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for BSX, with its range and direction at a glance.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Investors usually follow BSX for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 67/100 while there is no strong bear warning from the current data. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$907M
TTM (2026-06-30)
ROE
15.3%
Return on equity
ROA
6.2%
Return on assets
Debt / equity
0.51
Lower is usually safer.
P/B ratio
2.72
Useful for book value support.
85/100
Direction
Range-bound
Main supports
Valuation still leaves room versus fair value and analyst anchors.
Trading liquidity looks supportive for the forecast to transmit into price action.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Fair value
$54.76
Analyst view
Buy
Analyst target
$62.69
Forecast refresh
Updated just now
Quality score
67
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Rising
+3.9% across the latest saved price window.
Volatility
Low
Beta is 0.57. Price has historically moved more calmly than the wider market.
52-week position
9% of range
Price is trading close to its 52-week low.
Volume confirmation
N/A
Comparable volume data is not available.
BSX
Boston Scientific Corporation
Price: $48.55
P/E: 18.963562
Yield: N/A
ABBV
AbbVie Inc.
Price: $256.23
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.25
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $158.19
P/E: 27.310226
Yield: 0.0%
Industry
Medical Devices
Employees
59000
Exchange
NYQ
Ticker
BSX
